日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

TE-1146, a novel anti-CD38-antibody-lenalidomide conjugate, demonstrates potent ex vivo anti-myeloma activity

TE-1146 是一种新型的抗 CD38 抗体-来那度胺偶联物，表现出强大的体外抗骨髓瘤活性。

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2025.288692
Cheng, Shih-Syuan; Jiang, Jing-Gu; Lin, Shih-Chiang; Yu, Yueh-Hsiang; Chang, Tse Wen; Lim, Carmay; Yu, Yuan-Bin; Chu, Hsing-Mao
CD3
CD38
骨髓瘤
发表日期：2026
文献求助 收藏

2FA-Platform Generates Dual Fatty Acid-Conjugated GLP-1 Receptor Agonist TE-8105 with Enhanced Diabetes, Obesity, and NASH Efficacy Compared to Semaglutide.

2FA平台生成双脂肪酸偶联GLP-1受体激动剂TE-8105，与司美格鲁肽相比，其在治疗糖尿病、肥胖症和NASH方面具有更强的疗效

期刊:Journal of Medicinal Chemistry
影响因子:6.8
doi:10.1021/acs.jmedchem.4c02153
Wong Mun-Teng, Lin Pei-Hsuan, Lin Wei-Chen, Peng Chi-Jiun, Wright Jon D, Lee Hui-Ju, Chu Hsing-Mao, Lim Carmay, Chang Tse Wen
代谢
糖尿病
血管生成
发表日期：2025
文献求助 收藏

An Antibody-Drug Conjugate for Multiple Myeloma Prepared by Multi-Arm Linkers

利用多臂连接子制备的多发性骨髓瘤抗体-药物偶联物

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202307852
Yu, Yueh-Hsiang; Tian, Wei-Ting; Grauffel, Cédric; Lin, Wei-Chen; Hsieh, Ming-Yu; Wu, Pei-Wen; Lee, Hui-Ju; Peng, Chi-Jiun; Lin, Pei-Hsuan; Chu, Hsing-Mao; Lim, Carmay; Chang, Tse Wen
骨髓瘤
多发性骨髓瘤
发表日期：2024
文献求助 收藏

Site-specific Conjugation of 6 DOTA Chelators to a CA19-9-targeting scFv-Fc Antibody for Imaging and Therapy

将6种DOTA螯合剂位点特异性偶联到靶向CA19-9的scFv-Fc抗体上，用于成像和治疗

期刊:Journal of Medicinal Chemistry
影响因子:6.8
doi:10.1021/acs.jmedchem.3c00753
Chen, Li-An; Yu, Yueh-Hsiang; Tian, Wei-Ting; Lin, Wei-Chen; Grauffel, Cédric; Wu, Chun-Yi; Chen, Chuan-Lin; Lim, Carmay; Chu, Hsing-Mao; Chang, Tse-Wen; Peng, Chi-Jiun
发表日期：2023
文献求助 收藏